Sonata Capital Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$389K Buy
337
+1
+0.3% +$1.18K 0.12% 92
2026
Q2
$404K Hold
336
– – 0.13% 91
2026
Q1
$309K Sell
336
-25
-7% -$25.3K 0.11% 96
2025
Q4
$388K Buy
361
+50
+16% +$47.8K 0.14% 88
2025
Q3
$237K Buy
311
+1
+0.3% +$744 0.09% 116
2025
Q2
$242K Buy
+310
New +$241K 0.1% 109

Other funds holding LLY

Sonata Capital Group's LLY Position: Q3 2026 in Review

Sonata Capital Group increased its Eli Lilly (LLY) stake by 0.3% in Q3 2026, buying an estimated $1.18K and bringing the position to 337 shares worth $389K. The position accounts for 0.12% of the portfolio, ranked #92.

Sonata Capital Group first reported a position in LLY in Q2 2025 and has held it in 6 quarters since. The position peaked at $404K in Q2 2026. 4,568 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Sonata Capital Group held 337 shares of Eli Lilly worth $389K as of Q3 2026.
  • Sonata Capital Group bought 1 Eli Lilly share in Q3 2026, an estimated $1.18K.
  • Eli Lilly made up 0.12% of Sonata Capital Group's portfolio in Q3 2026, its #92 holding.
  • Sonata Capital Group first reported a position in Eli Lilly in Q2 2025 and has held it in 6 quarters since.
  • Sonata Capital Group's Eli Lilly position peaked at $404K in Q2 2026.
  • 4,568 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Sonata Capital Group's 13F filing for Q3 2026, filed 19 Oct 2026.